“Conclusion During treatment with IFNB , increasing serum concentrations of alpha-tocopherol were associated with reduced odds for simultaneous and subsequent MRI disease activity in RRMS patients.”
“… interferon beta (IFNB) treatment, each …/L increase in alpha-tocopherol reduced the odds (CI 95%) for simultaneous new T2 lesions by 36.8 (0.5–59.8) %, p = 0.048, … for combined unique activity by 35.4 (1.6–57.7) %, p = 0.042, in a hierarchical regression model.”